Intracranial infections post-neurosurgical procedure pose substantial morbidity and mortality risks. Myroides odoratimimus, an opportunistic gram-negative pathogen, represents a real challenge because of limited clinical experience. This article details the second reported case of intracranial M. odoratimimus infection associated with external ventricular drains in an immunocompetent adult. Treatment involved a 21-day course of intravenous antibiotherapy using meropenem and vancomycin. This case underscores the complexity of managing rare complications, providing insights into therapeutic strategies for this challenging condition.
Get full access to this article
View all access options for this article.
References
1.
GreenbergSM, ZiaiWC, CordonnierC, et al.American Heart Association/American Stroke Association. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American heart association/American stroke association. Stroke, 2022; 53(7):e282–e361; doi: 10.1161/STR.0000000000000407
2.
MendelowAD, GregsonBA, FernandesHM, et al.STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet, 2005; 365(9457):387–397; doi: 10.1016/S0140-6736(05)17826-X
3.
de Oliveira ManoelAL. Surgery for spontaneous intracerebral hemorrhage. Crit Care, 2020; 24(1):45; doi: 10.1186/s13054-020-2749-2
4.
MartinRM, ZimmermannLL, HuynhM, et al.Diagnostic approach to health care- and device-associated central nervous system infections. J Clin Microbiol, 2018; 56(11):e00861-18; doi: 10.1128/JCM.00861-18
5.
JamjoomAAB, JoannidesAJ, PoonMT, et al.British Neurosurgical Trainee Research Collaborative. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry, 2018; 89(2):120–126; doi: 10.1136/jnnp-2017-316415
6.
JiangLZ, ShenY, LiangF, et al.Intracranial myroides odoratimimus infection after EVD successfully treated with intravenous plus intraventricular tigecycline: A case report. Infect Drug Resist, 2023; 16:1955–1963; doi: 10.2147/IDR.S403088
7.
LorenzinG, PiccinelliG, CarlassaraL, et al.Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism. Antimicrob Resist Infect Control, 2018; 7:96; doi: 10.1186/s13756-018-0391-4
8.
MohammadMK, AjeelAA, BaqerBAAA. Clinical and pathogenesis overview of myroides sp. Infection. MINAR Int J Appl Sci Technol, 2021; 03(04):9–16.
9.
KhanU, PandeyE, GandhamN, et al.A case series and literature review of infections due to Myroides spp.: Identification of contributing factors and emerging antibiotic susceptibility trends. Access Microbiol, 2023; 5(5):acmi000549.v2; doi: 10.1099/acmi.0.000549.v2
10.
KtariS, MnifB, KoubaaM, et al.Nosocomial outbreak of myroides odoratimimus urinary tract infection in a tunisian hospital. J Hosp Infect, 2012; 80(1):77–81; doi: 10.1016/j.jhin.2011.09.010
11.
ElantamilanD, LyngdohVW, ChoudhuryB, et al.Septicaemia caused by Myroides sp.: A case report. JMM Case Rep, 2015; 2(5):e000097.
12.
HuSH, YuanSX, QuH, et al.Antibiotic resistance mechanisms of Myroides sp. J Zhejiang Univ Sci B, 2016; 17(3):188–199; doi: 10.1631/jzus.B1500068
13.
KuaiL, OngSE, MadisonJM, et al.AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics. Chem Biol, 2011; 18(7):891–906; doi: 10.1016/j.chembiol.2011.03.017
14.
KurtAF, MeteB, HousseinFM, et al.A pan-resistant Myroides odoratimimus catheter-related bacteremia in a COVID-19 patient and review of the literature. Acta Microbiol Immunol Hung online March 21, 2022; doi: 10.1556/030.2022.01702
15.
LaurettiL, D’AlessandrisQG, FantoniM, et al.First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii. J Neurosurg, 2017; 127(2):370–373; doi: 10.3171/2016.6.JNS16352
16.
HuangQ, ZhangX, JiaA, et al.The Pharmacokinetics/pharmacodynamics and neurotoxicity of tigecycline intraventricular injection for the treatment of extensively drug-resistant acinetobacter baumannii intracranial infection. Infect Drug Resist, 2022; 15:4809–4817; doi: 10.2147/IDR.S377772
17.
BaldwinCM, Lyseng-WilliamsonKA, KeamSJ. Meropenem: A review of its use in the treatment of serious bacterial infections. Drugs, 2008; 68(6):803–838; doi: 10.2165/00003495-200868060-00006
